Full Text
EE731 Ropeginterferon Alfa-2B Is Cost-Effective to Manage Low-Risk Patients With Polycythemia Vera As Compared to Phlebotomy Only

Abstract

Authors

E Walter T Barbui

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×